Literature DB >> 8156124

A simplified technique of ex situ hepatic surgical treatment.

A Sauvanet1, B Dousset, J Belghiti.   

Abstract

A simplified technique of "ex situ" hepatic surgical treatment, indicated when conventional operation is precluded by a huge centrohepatic tumor or the need of suprahepatic vascular reconstruction, or both, is described. Wide access on all parts of the liver is provided by section of infrahepatic and suprahepatic vena cava, but the continuity of the portal triad is preserved. This technical modification reduces the duration of the anhepatic phase and avoids the risks of artery and biliary reconstruction.

Entities:  

Mesh:

Year:  1994        PMID: 8156124

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  4 in total

1.  Surgical treatment of hepatocellular carcinoma originating from the caudate lobe.

Authors:  M C Yang; P O Lee; J C Sheu; M Y Lai; R H Hu; C K Wei
Journal:  World J Surg       Date:  1996-06       Impact factor: 3.352

2.  Ex-situ liver surgery without veno-venous bypass.

Authors:  Ke-Ming Zhang; Xiong-Wei Hu; Jia-Hong Dong; Zhi-Xian Hong; Zhao-Hai Wang; Gao-Hua Li; Rui-Zhao Qi; Wei-Dong Duan; Shao-Geng Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

3.  Modified ante situm liver resection without use of cold perfusion nor veno-venous bypass for treatment of hepatic lesions infiltrating the hepatocaval confluence.

Authors:  F Oldhafer; K I Ringe; K Timrott; M Kleine; O Beetz; W Ramackers; S Cammann; J Klempnauer; F W R Vondran; H Bektas
Journal:  Langenbecks Arch Surg       Date:  2018-02-22       Impact factor: 3.445

4.  Atrial reconstruction, distal gastrectomy with Ante-situm liver resection and autotransplantation for hepatocellular carcinoma with atrial tumor thrombus: A case report.

Authors:  Tuerhongjiang Tuxun; Shadike Apaer; Gang Yao; Zhipeng Wang; Shensen Gu; Qi Zeng; Aidan Aizezijiang; Jing Wu; Nuerzhatijiang Anweier; Jinming Zhao; Tao Li
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.